| Specification | Description |
|---|---|
| Drug Class | Triazole antifungal |
| Mechanism of Action | Inhibits fungal cytochrome P-450-dependent enzymes |
| Route of Administration | Oral and intravenous |
| Half-life | 6-8 hours |
| Protein Binding | Approximately 58% |
| Metabolism | Hepatic metabolism |
| Excretion | Primarily through urine (mostly as metabolites) |
| Dosage Forms | Tablets, intravenous solution |
| Available Strengths | Tablets: 50 mg, 200 mg; IV: 200 mg in 20 mL vial |
| Storage | Store at room temperature, protect from light |
| Stability | Stable for up to 24 hours after reconstitution |
| Common Side Effects | Visual disturbances, liver abnormalities, rash |
| Contraindications | Known hypersensitivity to Voriconazole or related compounds |
Copyright © 2023. All rights reserved. Design By Techno Mantra
Copyright © [year] – All rights reserved. Design By Technomantra India / Technomantra Global / Technomantra us / Technomantra Canada Technomantra local / Technomantra Australia